VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA ...
This milestone represents the first significant deliverable in Rakovina’s partnership with Variational AI, which leverages their state-of-the-art Enki™ platform to fast-track the discovery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback